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20 miRNAs in complex showed that decreased expression was
observed much less frequently in the samples with a later RCC
stage than in samples with early RCC stage. For example, in a
tumor sample of a patient with stage IV (T3aN2M1) expression
was reduced only for miR-129 and miR-375 in 10 times for each
miRNA, while the expression of miR-9 was increased. In samples
with stage III expression was reduced in 2 or 4 out of the selected
20 miRNAs, in samples with stage I expression decrease was
observed for 9 out of 20 studied miRNAs. Since kidney tissue from
the same patient was taken as the control, it could be assumed
that the absence of expression decrease in studied 20 miRNAs
in tumors was due to a decrease in their expression in the sur-
rounding tissues, which eliminated the difference in the quantity
of miRNAs in tumors and surrounding tissues. An additional
experiment, in which kidney tissue from healthy donors with
no history of cancer was taken as a control, showed decreased
expression of miR-125b, miR-124a, miR-127, miR-203, miR-34c-
3p, miR-9, miR-129, miR- 34b in histologically normal tissue of
patients with RCC. There was identified a group of miRNAs out
of studied 20 ones which may be involved in the progression of
RCC, they were at least miR-129, miR-375 and miR-9. Expression
characteristics of miRNAs require further study and may be used
as biomarkers.
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Background: Heparansulfate (HS) is a glycosaminoglycan pre-
sent on the cell surface and in the extracellular matrix, which
interacts with diverse signal molecules and is essential for many
physiological processes including embryonic development, cell
growth, inflammation, and blood coagulation. D-glucuronyl C5-
epimerase (GLCE) is a crucial enzyme in HS synthesis, converting
D-glucuronic acid (GlcA) to L-iduronic acid (IdoA) to increase HS
flexibility. Aberrant modification may result in wrong structure
of polysaccharide chains of HS and defects of microenvironment
associated with malignant transformation.We previously
experimentally identified the GLCE polymorphism Ile597Val. Its
localization close to the activity center of the enzyme and differ-
ent physical parameters of the involved amino acids suggest that
the polymorphism is functional. So, three different variants of
GLCE dimers with different enzymatic activity may exist in
heterozygous carriers. Bioinformatics’ search (PubMed resource)
revealed interracial variations in allele frequency distribution.
Unusual high frequency of allele G was shown for black
race (45%) compared with white race (17%). Taking into account
the increased resistance of negroid race to breast cancer, we
assume a potential involvement of the GLCE polymorphism in
breast cancer.
Aim: The estimation of effects of GLCE functional polymor-
phism A2017G (Ile597Val) on the gene expression levels in normal
and breast cancer cells and LOH in breast tumors.
Materials and methods: Breast cancer patients (n = 144.) had
histologically verified diagnoses. Blood and breast cancer tissue
samples as well as matched control tissues were collected from
each patient during surgery. Genomic DNAwas isolated by phenol
extraction. Total RNA was isolated by TRIZol, RNA quantity was
accessed by Qubit instrument with appropriate reagents and
cDNA was obtained using First Strand cDNA Synthesis kit. SNP
A2017G (rs3865014) was analyzed by Custom Real-Time SNPArray
and GLCE expression levels were determined using Taq-Man-
based Real-Time PCR (Applied Biosystems). Statistical analysis
was carried out using a Statistika 9.0 software.
Results: AA genotype carriers had a 2-fold increase in GLCE
mRNA levels in tumors compared with control surrounding
tissues (0.37 ± 0.77 versus 0.17 ± 0.16, respectively, p < 0.05). Oppo-
sitely, AG genotype carriers had a 1.5-fold decrease in GLCE mRNA
levels in tumors compared with control surrounding tissues
(0.39 ± 0.29 versus 0.58 ± 0.33, respectively, p < 0.05 ). However, in
any case,the GLCE expression in both normal tissues and breast
tumors was more active in AG genotype carriers than in AA
carriers. It is known that LOH is often associated with molecular
mechanisms of carcinogenesis, we studied this process for the
same patients. According our results, LOH was detected in about
10% of cases (5/52 patients), among which G was lost in 3 patients
and A was lost in 2 patients.
Conclusion: The obtained data show a possible association
between GLCE Ile597Val polymorphism and breast cancer,
although the nature of the association remains ambiguous.
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Malignant gliomas are fast-growing, heterogeneous and inva-
sive brain tumors strongly infiltrated by non-tumor cells. Glioma
attracts variety of immune cells, in particular microglia/
macrophages and re-program these cells into immunosuppres-
sive, tumor-supporting cells. Factors responsible for
pro-invasive macrophage polarization and shaping tumor
microenvironment in tumor-supporting manner are poorly
known. We analyzed glioma secretome using proteomical
approach and identified lactadherin (Mfge8) and osteopontin
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